Stemtech (STEK) Profit After Tax Growth (3y) (2015 - 2025)

Stemtech (STEK) Profit After Tax Growth (3y) (2015 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 51.23%
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 2.88%
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 4.50%
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 69.79%
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 66.11%
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -17.90%
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 33.65%
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 253.53%
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -109.16%
10 Stemtech - - 354,677.00 -41.89%

Historic Data

Download Data
DateValue
Dec 31, 2025 -41.89%
Sep 30, 2025 -26.96%
Jun 30, 2025 77.18%
Mar 31, 2025 -42.01%
Dec 31, 2024 21.54%
Sep 30, 2024 39.61%
Jun 30, 2024 -0.47%
Mar 31, 2024 -102.49%
Nov 30, 2020 16.46%
May 31, 2020 15.09%
Feb 29, 2020 9.16%
Nov 30, 2019 3.91%
Aug 31, 2019 -3.44%
May 31, 2019 3.55%
Feb 28, 2019 -30.21%
Nov 30, 2018 -3.33%
Aug 31, 2018 -10.04%
May 31, 2018 -49.44%
Feb 28, 2018 -7.21%
Nov 30, 2017 -60.15%